Zimmer Biomet Holdings ZBH
NYSE ZBH
$99.01 -1.75 (-1.74%)
At close: Aug 20, 2026 · 4:00 PM EDT

Zimmer Biomet Holdings (ZBH) Cash from Discontinued Operations (2021 - 2022)

Zimmer Biomet Holdings (ZBH) posted quarterly Cash from Discontinued Operations of 7000000.0 for Q2 2022, down 79.94% year-over-year from 34900000.0 in Q2 2021, and up 108.92% quarter-over-quarter from 78500000.0 in Q1 2022.

Zimmer Biomet Holdings (ZBH) Cash from Discontinued Operations (2021 - 2022) Analysis & Trends

Zimmer Biomet Holdings' Cash from Discontinued Operations history runs 2 years deep, the most recent figure standing at 7000000.0 for Q2 2022.

  • In Q2 2022, Cash from Discontinued Operations fell 79.94% year-over-year to 7000000.0; the TTM figure through Mar 2023 stood at 7000000.0 (up 206.06% YoY), while the FY2022 annual figure was 71500000.0, down 175.34% from the prior year.
  • Cash from Discontinued Operations for Q2 2022 stood at 7000000.0, up from 78500000.0 in the prior quarter.
  • The five-year high for Cash from Discontinued Operations was 34900000.0 in Q2 2021, with the low at 78500000.0 in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -
10 Zimmer Biomet Holdings 19.04 Bn 18.63 Bn 1.54 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2022 7.00 Mn
Jun 30, 2022 7.00 Mn
Mar 31, 2022 -78.50 Mn
Mar 31, 2022 -78.50 Mn
Dec 31, 2021 28.10 Mn
Dec 31, 2021 28.10 Mn
Sep 30, 2021 8.90 Mn
Sep 30, 2021 8.90 Mn
Jun 30, 2021 34.90 Mn
Jun 30, 2021 34.90 Mn
Mar 31, 2021 23.00 Mn
Mar 31, 2021 23.00 Mn